EIF2AK3 and melanoma: We first observed in these cells that the anti-ErbB3 antibody A3 was able to induce strong ErbB3 downregulation as previously shown in melanoma cells and that the antibody was able to decrease, albeit to a variable extent, heregulin-induced pErbB3, pAKT and pERK signaling [36].